Find comprehensive information on diagnosing yeast infections (candidiasis) during pregnancy. This resource covers clinical documentation, medical coding (ICD-10 codes), diagnostic criteria, and treatment considerations for vaginal candidiasis in pregnant women. Learn about relevant healthcare guidelines, differential diagnosis, and patient education for managing yeast infections throughout pregnancy. Explore resources for healthcare professionals focused on accurate documentation and coding for this common prenatal condition.
Also known as
Candidiasis of vulva and vagina
Yeast infection affecting the vulva and vagina.
Other infections of genital tract in pregnancy
Infections affecting the genital tract during pregnancy, excluding specified conditions.
Candidiasis, unspecified
Yeast infection without specific location.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the yeast infection vulvovaginal?
When to use each related code
| Description |
|---|
| Vaginal yeast infection during pregnancy. |
| Bacterial vaginosis (BV) in pregnancy. |
| Trichomoniasis in pregnancy. |
Coding B37.3 without specifying site (vulvovaginal, oral, etc.) leads to inaccurate data and potential claim denials. Use B37.4 for vulvovaginal candidiasis in pregnancy.
Failing to capture related conditions like gestational diabetes (O24.4XX) which increases yeast infection risk, impacts risk adjustment and quality metrics.
Coding yeast infection based on symptoms alone without confirmatory lab tests may trigger audits and denials. Ensure proper documentation supports the diagnosis code.
Patient presents with complaints consistent with vulvovaginal candidiasis (yeast infection) during pregnancy. She reports pruritus, vulvar erythema, and a thick, white, cottage cheese-like vaginal discharge. Onset of symptoms began approximately one week ago. Patient denies fever, chills, abdominal pain, or malodorous discharge. She is currently in her second trimester at 22 weeks gestation. Physical examination reveals vulvar and vaginal erythema with white plaques adherent to the vaginal walls. A wet mount preparation with potassium hydroxide (KOH) confirms the presence of budding yeast and pseudohyphae, consistent with the diagnosis of Candida vulvovaginitis. Differential diagnoses considered include bacterial vaginosis and trichomoniasis, but these were ruled out based on clinical presentation and microscopic examination. Treatment plan includes topical clotrimazole 1% cream intravaginally for seven days. Patient education provided regarding proper application of medication, avoidance of irritants, and the importance of completing the full course of treatment. Risks and benefits of treatment during pregnancy were discussed. Follow-up scheduled in two weeks to assess symptom resolution. ICD-10 code B37.3 (Candidal vulvovaginitis) and relevant pregnancy codes will be applied.